Given that retatrutide likely causes similar or greater gastroparesis than tirzepatide, the same oral absorption concerns would apply
People with very high triglyceride levels should work closely with their healthcare provider to manage these levels before starting treatment, as elevated triglycerides are a known pancreatitis risk factor
CAS Number 2381089-83-2 Molecular Formula C221H342N46O68 Molecular Weight 4731.4 g/mol Half-Life ~6 days (research reports) Sources & References Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Jastreboff AM, et al
It's worth noting that the added nutrients are at a pretty low level
Figure 1: Data taken from Bays et al., 2026 The published safety, tolerability, and discontinuation data were broadly consistent with what youd expect from an incretin-based program and importantly did not look concerning versus established injectables
Important interactions to be aware of include: Other central nervous system depressants (e.g., benzodiazepines) Alcohol Medications that affect liver function Always inform healthcare providers about all medications being taken to avoid harmful interactions